215 related articles for article (PubMed ID: 23736363)
1. Addiction potential of phentermine prescribed during long-term treatment of obesity.
Hendricks EJ; Srisurapanont M; Schmidt SL; Haggard M; Souter S; Mitchell CL; De Marco DG; Hendricks MJ; Istratiy Y; Greenway FL
Int J Obes (Lond); 2014 Feb; 38(2):292-8. PubMed ID: 23736363
[TBL] [Abstract][Full Text] [Related]
2. A study of abrupt phentermine cessation in patients in a weight management program.
Hendricks EJ; Greenway FL
Am J Ther; 2011 Jul; 18(4):292-9. PubMed ID: 20592662
[TBL] [Abstract][Full Text] [Related]
3. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
Bays H
Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
[TBL] [Abstract][Full Text] [Related]
4. Topiramate + phentermine. An excessively dangerous appetite-suppressant combination.
Prescrire Int; 2013 Mar; 22(136):61-4. PubMed ID: 23593686
[TBL] [Abstract][Full Text] [Related]
5. Effects on weight reduction and safety of short-term phentermine administration in Korean obese people.
Kim KK; Cho HJ; Kang HC; Youn BB; Lee KR
Yonsei Med J; 2006 Oct; 47(5):614-25. PubMed ID: 17066505
[TBL] [Abstract][Full Text] [Related]
6. Echocardiographic improvement over time after cessation of use of fenfluramine and phentermine.
Hensrud DD; Connolly HM; Grogan M; Miller FA; Bailey KR; Jensen MD
Mayo Clin Proc; 1999 Dec; 74(12):1191-7. PubMed ID: 10593346
[TBL] [Abstract][Full Text] [Related]
7. Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity.
Bays HE; Gadde KM
Drugs Today (Barc); 2011 Dec; 47(12):903-14. PubMed ID: 22348915
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity.
Jordan J; Astrup A; Engeli S; Narkiewicz K; Day WW; Finer N
J Hypertens; 2014 Jun; 32(6):1178-88. PubMed ID: 24621808
[TBL] [Abstract][Full Text] [Related]
9. Coadministration of Canagliflozin and Phentermine for Weight Management in Overweight and Obese Individuals Without Diabetes: A Randomized Clinical Trial.
Hollander P; Bays HE; Rosenstock J; Frustaci ME; Fung A; Vercruysse F; Erondu N
Diabetes Care; 2017 May; 40(5):632-639. PubMed ID: 28289041
[TBL] [Abstract][Full Text] [Related]
10. Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial.
Aronne LJ; Halseth AE; Burns CM; Miller S; Shen LZ
Obesity (Silver Spring); 2010 Sep; 18(9):1739-46. PubMed ID: 20094043
[TBL] [Abstract][Full Text] [Related]
11. Topiramate and phentermine: a long story...
Prescrire Int; 2013 Mar; 22(136):62. PubMed ID: 23593687
[No Abstract] [Full Text] [Related]
12. Effects of a meal replacement system alone or in combination with phentermine on weight loss and food cravings.
Moldovan CP; Weldon AJ; Daher NS; Schneider LE; Bellinger DL; Berk LS; Hermé AC; Aréchiga AL; Davis WL; Peters WR
Obesity (Silver Spring); 2016 Nov; 24(11):2344-2350. PubMed ID: 27664021
[TBL] [Abstract][Full Text] [Related]
13. Scleroderma in the Setting of Long-term Intermittent Phentermine Use.
Beer J; Maderal A
J Drugs Dermatol; 2020 Nov; 19(11):1126. PubMed ID: 33196751
[No Abstract] [Full Text] [Related]
14. Plasma phentermine levels, weight loss and side-effects.
Douglas A; Douglas JG; Robertson CE; Munro JF
Int J Obes; 1983; 7(6):591-5. PubMed ID: 6654575
[TBL] [Abstract][Full Text] [Related]
15. Open treatment of overweight binge eaters with phentermine and fluoxetine as an adjunct to cognitive-behavioral therapy.
Devlin MJ; Goldfein JA; Carino JS; Wolk SL
Int J Eat Disord; 2000 Nov; 28(3):325-32. PubMed ID: 10942919
[TBL] [Abstract][Full Text] [Related]
16. Appetite suppressants as adjuncts for weight loss.
Wilbert B; Mohundro BL; Shaw V; Andres A
Am Fam Physician; 2011 Apr; 83(7):1-2. PubMed ID: 21674993
[No Abstract] [Full Text] [Related]
17. The fenfluramine/phentermine combination for weight loss.
Garrett SD; Cupp MJ
Nurse Pract; 1997 Aug; 22(8):166, 168, 170. PubMed ID: 9279853
[No Abstract] [Full Text] [Related]
18. A case of profound weight loss secondary to use of phentermine.
Uwaifo GI; Melcescu E; McDonald A; Koch CA
J Miss State Med Assoc; 2009 Dec; 50(12):407-15. PubMed ID: 20806811
[TBL] [Abstract][Full Text] [Related]
19. Phentermine: an appetite-suppressant amphetamine classified as a narcotic in France. Is a combination with topiramate on the horizon?
Prescrire Int; 2012 Sep; 21(130):209. PubMed ID: 23016252
[TBL] [Abstract][Full Text] [Related]
20. Effects of liraglutide plus phentermine in adults with obesity following 1 year of treatment by liraglutide alone: A randomized placebo-controlled pilot trial.
Tronieri JS; Wadden TA; Walsh OA; Berkowitz RI; Alamuddin N; Gruber K; Leonard S; Chao AM
Metabolism; 2019 Jul; 96():83-91. PubMed ID: 30902750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
